Table 4.
Haplogroup distribution in controls and patients with T2DM (cohorts 1, 2, and 3).
| Parsed haplogroup | Haplogroup | Controls (total %) | T2DM (total %) | Total (total %) |
|---|---|---|---|---|
| D5 | D5 | 119 (10.76) | 32 (2.89) | 151 (13.65) |
| F4 | F4 | 33 (2.98) | 5 (0.45) | 38 (3.44) |
| N9a | N9a | 58 (5.24) | 10 (0.90) | 68 (6.15) |
| Macro-M | D | 73 (6.60) | 41 (3.71) | 114 (10.31) |
| E | 8 (0.72) | 4 (0.36) | 12 (1.08) | |
| G | 12 (1.08) | 12 (1.08) | 24 (2.17) | |
| M* | 23 (2.08) | 12 (1.08) | 35 (3.16) | |
| M10 | 13 (1.18) | 4 (0.36) | 17 (1.54) | |
| M7 | 81 (7.32) | 51 (4.61) | 132 (11.93) | |
| M8 | 46 (4.16) | 26 (2.35) | 72 (6.51) | |
| M9 | 12 (1.08) | 4 (0.36) | 16 (1.45) | |
| Macro-N | A | 28 (2.53) | 12 (1.08) | 40 (3.62) |
| B | 125 (11.30) | 74 (6.69) | 199 (17.99) | |
| F | 116 (10.49) | 42 (3.80) | 158 (14.29) | |
| R | 19 (1.72) | 11 (0.99) | 30 (2.71) | |
| Total | 766 (69.26) | 340 (30.74) | 1106 | |